Learn, Analyse & Invest
only with
only with
+91
Download Orca
Evexia Lifecare Ltd.
Evexia Lifecare
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹1.91 Cr.
| EX-Date | Purpose |
|---|---|
| 25 05 2021 | Stock Split |
| 30 06 2021 | Audited Results |
| 30 07 2021 | Inter alia,to discuss and consider the following business: 1. To Sale the entire stake of the Company held in its Subsidiary Companies namely Kavit Hospitality Private Limited and Kavit Infra Project Private Limited 2. Any other item with the permission of the Chair and Majority of Directors. |
| 11 08 2021 | Quarterly Results |
| 28 08 2021 | A.G.M. Inter alia, to transact the following business: 1. To call 30th Annual General Meeting of the Company and fix the day, date and time of the meeting. 2. To consider and approve the notice of 30th Annual General Meeting and Directors Report for the year ended on 31st March, 2021. 3. To fix the date of book closure of the Company. 4. Any other item with the permission of the Chair and Majority of Directors. |
| 12 11 2021 | Quarterly Results |
| 06 12 2021 | Inter alia, to transact the following business; 1. To call 30th Annual General Meeting of the Company and fix the day, date and time of the meeting. 2: To consider and approve the notice of 30th Annual General Meeting and Directors? Report for the year ended on 31st March, 2021. 3. To fix the date of book closure of the Company. 4. Any other item with the permission of the Chair and Majority of Directors. |
| 25 01 2022 | Quarterly Results & Inter alia, to approve: 1. Raising of funds through issue of convertible or exchangeable securities, including but not limited to, warrants, depository receipts, FCCBs or any combination thereof, by way of a preferential offer, a private placement, qualified institutions placement or a combination thereof, or such other methods or combinations as may be decided, in India or abroad, and pricing thereof, as may be considered appropriate, subject to the approval of the members of the Company, and other regulatory and/or statutory approvals, as applicable. 3 To take note for appointment of Mr. Anmol Shanwlesha as Company Secretary and compliance officer of the company. 4. Any other item with the permission of the Chair and Majority of Directors. |
| 04 02 2022 | Stock Split |
| 12 04 2022 | Audited Results |
| 29 04 2022 | Inter alia, to transact the following business: 1. To consider fixing of record date in connection with Sub-Division (Split) of 1 (One) Equity Share of the Company having face value of Rs. 2/- each (fully paid) to be sub- divided into2 (Two) Equity Shares of face value of Re. 1/- each (fully paid). 2. Raising of funds through issue of convertible or exchangeable securities, including but not limited to, warrants, depository receipts, FCCBs or any combination thereof, by way of a preferential offer, a private placement, qualified institutions placement or a combination thereof, or such other methods or combinations as may be decided, in India or abroad, and pricing thereof, as may be considered appropriate, subject to the approval of the members of the Company, and other regulatory and/or statutory approvals, as applicable. 3. Any other item with the permission of the Chair and Majority of Directors |
| 23 07 2022 | Quarterly Results |
| 30 08 2022 | Inter alia, to transact the following business; 1. To call 31st Annual General Meeting of the Company and to fix the day, date and time of the meeting. 2. To consider and approve the notice of 31st Annual General Meeting and Director?s Report of the Company along with all annexure thereof for the year ended on 31st March, 2022. 3. To consider and approve the Reappointment of Mr. Jayesh R. Thakkar (DIN: 01631093) as Managing Director of the company. 4. Any other item with the permission of the Chair and Majority of Directors. |
| 19 10 2022 | Quarterly Results |
| 21 10 2022 | Quarterly Results |
| 07 11 2022 | Inter alia, to transact the following business :- 1. Raising of funds through issue of equity shares, and/or foreign currency convertible bonds (?FCCB?),and/or non-convertible debentures, and/or any other eligible instruments or securities representing equity shares or convertible into or exchangeable for equity shares, through qualified institutions placement, rights issue, or such other permissible mode or combination thereof, in accordance with the relevant provisions of applicable law. 2. Any other item with the permission of the Chair and Majority of Directors. |
| 13 02 2023 | Quarterly Results |
| 09 03 2023 | Inter alia, to transact the following business; 1. To Consider and approve conversion of upto 11 (Eleven) Foreign Currency Convertible Bonds issued to Global Focus Fund Limited into equity shares. 2. To increase Authorised Share capital of the Company from Rs. 66,45,00,000/- to Rs. 125,00,00,000/- subject to necessary approvals. 3. To Call Extra Ordinary General Meeting of the Company and to fix the day, date and time of the meeting. 4. Any other item with the permission of the Chair and Majority of Directors. |
| 28 03 2023 | Independent Director Meeting |
| 16 05 2023 | Issue Of Warrants & Increase in Authorised Capital & Inter alia, to transact the following business; 1. To Increase in Authorized Share Capital of the Company, subject to approval of the members 2. To Consider and discuss the issue of warrants to Promoters and Promoters Group on the preferential basis pursuant to SEBI (Issue of Capital & Disclosures Requirements) Regulations, 2018 subject to necessary approvals. 3. To take note of Resignation of Mr. Salil Shashikant Patel from the post of Director w.e.f. 11.05.2023 4. Any other Business with the permission of Chair and majority of directors. Kindly take the same on your record. |
| 25 05 2023 | Audited Results |
| 27 05 2023 | Audited Results (Revised) |
| 10 08 2023 | Quarterly Results |
| 07 11 2023 | Quarterly Results |
| 09 11 2023 | Quarterly Results (Revised) |
| 09 02 2024 | Quarterly Results |
| 28 03 2024 | Independent Director Meeting |
| 20 09 2024 | Preferential Issue of shares & Issue Of Warrants |
| 13 11 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results (Revised) |
| 14 02 2025 | Quarterly Results |
| 19 05 2025 | Audited Results(Cancelled) (Meeting Postponed) |
| 26 05 2025 | Audited Results(Cancelled) (Cancelled) |
| 29 05 2025 | Audited Results(Cancelled) (Cancelled) |
| 30 05 2025 | Audited Results |
| 12 08 2025 | Quarterly Results |
| 14 08 2025 | Quarterly Results (Revised) |
| 14 11 2025 | Quarterly Results |
| 14 02 2026 | Quarterly Results |
News
